Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

0.9881
Delayed Data
As of Feb 08
 -0.0919 / -8.51%
Today’s Change
0.88
Today|||52-Week Range
3.04
-18.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues8.4M8.3M14.4M11.1M
 
 
 
 
 
Cost of Goods Sold5.1M3.3M4.3M4.7M
 
 
 
 
 
Depreciation And Amortization351.1K378.6K390.4K400.8K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M4.7M9.7M6.0M
 
 
 
 
 
General Expenses13.0M11.4M11.2M11.8M
 
 
 
 
 
Research And Development5.7M4.4M4.6M5.1M
 
 
 
 
 
Total Operating Expenses18.4M15.1M15.9M16.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.0M-6.7M-1.5M-5.8M
 
 
 
 
 
Other Expenses-8.0K-45.7K-45.2K29.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.0M-6.8M-1.5M-5.7M
 
 
 
 
 
Income Taxes-25.0K0.000.000.00
 
 
Net Income-10.1M-6.8M-1.5M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS131.7M131.7M144.7M154.8M
 
 
 
 
 
Shares To Calculate EPS Diluted131.7M131.7M144.7M154.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.05-$0.01-$0.04
 
 
 
 
 
EPS Diluted-$0.08-$0.05-$0.01-$0.04